Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-02
2000-01-04
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 51, 544 52, 544 73, 544105, 544116, 544119, 544353, 544354, 544355, 544356, 5142305, 5142348, 514249, A61K 31535, A61K 3154, C07D26536, C07D27916
Patent
active
060110317
ABSTRACT:
Novel antidiabetic compounds, their tautomeric forms, their derivatives, their analogues, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them; methods for preparing the antidiabetic compounds and their uses.
REFERENCES:
patent: 4873255 (1989-10-01), Yoshioka
patent: 5002953 (1991-03-01), Hindley
patent: 5037842 (1991-08-01), Goldstein
patent: 5468762 (1995-11-01), Malamas
patent: 5478851 (1995-12-01), Cantello
patent: 5478852 (1995-12-01), Olefsky
patent: 5478853 (1995-12-01), Regnier
patent: 5521201 (1996-05-01), Hindley
Messier, C. et al., Behavioral Brain Research, 75 (1966) 1-11.
Sohda, T. et al., Chem Pharm Bull. 30, 10 (1982), 3580-3600.
Clark, et al., J. Med. Chem 34 (1991) 319-325.
Dow, R.L. et al., J. Med. Chem 34 (1991) 1538-1544.
Hulin, et al., J. Med. Chem 35 (1992) 1853-1864.
Sohda, T. et al., J. Med. Chem 35 (1992) 2617-2626.
Goldstein, et al., J. Med. Chem. 36(1993) 2238-2240.
Cantello, et al. J. Med. Chem 37 (1994) 3977-3985.
M. Modan, et al., J. Clin. Invest. (1985) vol. 75, pp. 809-817.
O.G. Kolterman, et al., J. Clin. Invest. (1981) vol. 68, pp, 957-969.
E. Ferrannini, et al., The New England Journal of Medicine (1987) vol. 317, pp. 350-357.
D.C. Shen, et al., J. Clin. Endocrinol. Metab. (1988) vol. 66, pp. 580-583.
Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, pp. 1496-1497.
Clifford Bailey, "Potential New Treatments for Type 2 Diabetes", Chemistry & Industry, Jan. 19, 1998, pp. 53-57.
T. Antonucci, et al., "Imparied Glucose Tolerance is Normalized by Treatment with Thiazolidinedione Troglitazone" Diabetes Care, vol. 20, No. 2, Feb. 1997, pp. 188-193.
Alla Sekar Reddy
Bajji Ashok Chennaveerappa
Kalchar Shivaramayya
Lohray Braj Bhushan
Lohray Vidya Bhushan
Dr. Reddy's Research Foundation
Kessinger Ann M.
Reddy-Cheminor Inc.
Shah Mukund J.
LandOfFree
Azolidinediones useful for the treatment of diabetes, dyslipidem does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azolidinediones useful for the treatment of diabetes, dyslipidem, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azolidinediones useful for the treatment of diabetes, dyslipidem will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072816